Loading...
•
Sep 30, 2023
Atricure Q3 2023 Earnings Report
Reported strong revenue growth driven by global performance and strategic investments with meaningful operating leverage.
Key Takeaways
AtriCure reported a strong third quarter with worldwide revenue increasing by 18.1% year-over-year to $98.3 million. The company experienced growth in both U.S. and international markets, driven by adoption of their products. They also reported a net loss of $9.1 million, an improvement from the previous year, and a positive adjusted EBITDA of $4.7 million.
Worldwide revenue increased 18.1% year-over-year to $98.3 million.
U.S. revenue increased 17.1% year-over-year to $81.7 million.
International revenue increased 23.2% year-over-year to $16.6 million.
Adjusted EBITDA was positive at $4.7 million, an improvement of $5.4 million year-over-year.
Revenue by Geographic Location
Forward Guidance
Full year 2023 revenue is projected to be $394 million to $396 million, reflecting growth of approximately 19% to 20% over full year 2022. Management now expects full year 2023 positive adjusted EBITDA of approximately $18 million to $20 million, and full year 2023 adjusted loss per share of approximately $0.74 to $0.76.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...